Establishment of culturing system for ex-vivo expansion of angiogenic immature erythroid cells, and its application for treatment of patients with chronic severe lower limb ischemia

Journal of Molecular and Cellular Cardiology

Volumn 49, Issue 3, 2010, Pages 347-353

  Oda, Masato ^a   Toba, Ken ^a   Ozawa, Takuya ^a   Kato, Kiminori ^a   Yanagawa, Takao ^a   Ikarashi, Noboru ^a   Takayama, Tsugumi ^a   Suzuki, Tomoyasu ^a   Hanawa, Haruo ^a   Fuse, Ichiro ^a   Nakata, Kou ^a   Narita, Miwako ^b   Takahashi, Masuhiro ^b   Aizawa, Yoshifusa ^a  

^a NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Clinical trial; Erythroblast transplantation; Ex vivo expansion; Limb ischemia

Indexed keywords

ERYTHROPOIETIN; FLT3 LIGAND; MESSENGER RNA; SCATTER FACTOR; SOMATOMEDIN; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BUERGER DISEASE; CASE REPORT; CELL ISOLATION; CELL MATURATION; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CULTURE MEDIUM; ERYTHROID CELL; EX VIVO STUDY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; INCUBATION TIME; LEG ISCHEMIA; MALE; MOUSE; NONHUMAN; PAIN; PATIENT SAFETY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN ULCER; STEM CELL EXPANSION; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT RESPONSE;

EID: 77955246605     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.04.001     Document Type: Article

References (25)

1. Isner J.M., Asahara T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J. Clin. Invest. 1999, 103:1231-1236.
2. Yla-Herttuala S., Alitalo K. Gene transfer as a tool to induce therapeutic vascular growth. Nat. Med. 2003, 9:694-701.
3. De Haro J., Acin F., Lopez-Quintana A., Florez A., Martinez-Aguilar E., Varela C. Meta-analysis of randomized, controlled clinical trials in angiogenesis: gene and cell therapy in peripheral arterial disease. Heart Vessels 2009, 24:321-328.
4. Tateishi-Yuyama E., Matsubara H., Murohara T., Ikeda U., Shintani S., Masaki H. Therapeutic Angiogenesis using Cell Transplantation (TACT) study investigators: therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002, 360:427-435.
5. Oda M., Kato K., Toba K., Otaki K., Kitajima T., Ikarashi N. Prognostic factors of critical limb ischemia after autologous bone marrow implantation. J. Cardiol. 2007, 50:235-242.
6. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
7. Crosby J.R., Kaminski W.E., Schatteman G., Martin P.J., Raines E.W., Seifert R.A., et al. Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circ. Res. 2000, 87:728-730.
8. Ozawa T., Toba K., Kato K., Minagawa S., Saigawa T., Hanawa H. Erythroid cells play essential roles in angiogenesis by bone marrow cell implantation. J. Mol. Cell. Cardiol. 2006, 40:629-638.
9. Tordjman R., Delaire S., Plouët J., Ting S., Gaulard P., Fichelson S., et al. Erythroblasts are a source of angiogenic factors. Blood 2001, 97:1968-1974.
10. Neildez-Nguyen T.M., Wajcman H., Marden M.C., Bensidhoum M., Moncollin V., Giarratana M.C. Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo. Nat. Biotechnol. 2002, 20:467-472.
11. Kobune M., Kawano Y., Kato J., Ito Y., Chiba H., Nakamura K. Expansion of CD34+ cells on telomerized human stromal cells without losing erythroid-differentiation potential in a serum-free condition. Int. J. Hematol. 2005, 81:18-25.
12. Toba K., Hanawa H., Fuse I., Sakaue M., Watanabe K., Uesugi Y. Difference in CD22 molecules in human B cells and basophils. Exp. Hematol. 2002, 30:205-211.
13. Yoshida T., Hanawa H., Toba K., Watanabe H., Watanabe R., Yoshida K. Expression of immunological molecules by cardiomyocytes and inflammatory and interstitial cells in rat autoimmune myocarditis. Cardiovasc. Res. 2005, 68:278-288.
14. Iba O., Matsubara H., Nozawa Y., Fujiyama S., Amano K., Mori Y., et al. Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs. Circulation 2002, 106:2019-2025.
15. Lee G., Lo A., Short S.A., Mankelow T.J., Spring F., Parsons S.F., et al. Targeted gene deletion demonstrates that the cell adhesion molecule ICAM-4 is critical for erythroblastic island formation. Blood 2006, 108:2064-2071.
16. Rajagopalan S., Mohler E.R., Lederman R.J., Mendelsohn F.O., Saucedo J.F., Goldman C.K., et al. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation 2003, 108:1933-1938.
17. Loges S., Schmids T., Carmeliet P. "Antimyeloangiogenic" therapy for cancer by inhibiting PlGF. Clin. Cancer Res. 2009, 15:3648-3653.
18. Iwase T., Nagaya N., Fujii T., Itoh T., Murakami S., Matsumoto T. Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia. Cardiovasc. Res. 2005, 66:543-551.
19. Kalka C., Masuda H., Takahashi T., Kalka-Moll W.M., Silver M., Kearney M. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. USA 2000, 97:3422-3427.
20. Matsumoto T., Kano K., Kondo D., Fukuda N., Iribe Y., Tanaka N. Mature adipocyte-derived dedifferentiated fat cells exhibit multilineage potential. J. Cell. Physiol. 2008, 215:210-222.
21. Simons M., Annex B.H., Laham R.J., Kleiman N., Henry T., Dauerman H., et al. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation 2002, 105:788-793.
22. Morishita R., Aoki M., Hashiya N., Makino H., Yamasaki K., Azuma J., et al. Safety evaluation of clinical gene therapy using hepatocute growth factor to treat peripheral arterial disease. Hypertension 2004, 44:203-209.
23. Hirata A., Minamino T., Asanuma H., Fujita M., Wakeno M., Myoishi M., et al. Erythropoietin enhances neovascularization of ischemic myocardium and improves left ventricular dysfunction after myocardial infarction in dogs. J. Am. Coll. Cardiol. 2006, 48:176-184.
24. Jin D.K., Shido K., Kopp H.G., Petit I., Shmelkov S.V., Young L.M., et al. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat. Med. 2006, 12:557-567.
25. Takahashi M., Izawa A., Ishigatsubo Y., Fujimoto K., Miyamoto M., Horie T., et al. Therapeutic neovascularization by the implantation of autologous mononuclear cells in patients with connective tissue diseases. Curr. Pharm. Des. 2009, 15:2778-2783.